Published in 2016 – Ann Oncol 2016; 00: 1–12, 2016
Authors: M. Ladetto, C. Buske, M. Hutchings, M. Dreyling, G. Gaidano, S. Le Gouill, S. Luminari, C. Pott, A. Zamò, E. Zucca and the ESMO Lymphoma Consensus Conference Panel Members
In order to complement the already available European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with malignant lymphomas, ESMO organised a consensus conference on mature B-cell lymphomas and chronic lymphocytic leukaemia to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (i) the elderly patient, (ii) prognostic factors suitable for clinical use and (iii) the ‘ultra-high-risk’ group.
This manuscript presents recommendations on prognostic factors suitable for clinical use and focuses on the three less common lymphoproliferative malignancies: marginal zone lymphoma, mantle cell lymphoma and peripheral T-cell lymphomas.